EPH Receptor A4 Antikörper (C-Term)

Produktnummer ABIN391890

Produktdetails anti-EPH Receptor A4 Antikörper

Target: EPH Receptor A4 (EPHA4)

Bindungsspezifität: AA 875-904, C-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser EPH Receptor A4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This EphA4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 875-904 amino acids from the C-terminal region of human EphA4.

Klon: RB1590

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:2000. WB: 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze-thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots.

Haltbarkeit: 6 months

Referenzen für anti-EPH Receptor A4 Antikörper (ABIN391890)

Sun, Qian, Lu, Xu: "Lower and reduced expression of EphA4 is associated with advanced TNM stage, lymph node metastasis, and poor survival in breast carcinoma." in: Pathology international, Vol. 66, Issue 9, pp. 506-10, (2017) (PubMed).

Details zu EPH Receptor A4

Target: EPH Receptor A4 (EPHA4)

Andere Bezeichnung: EphA4 (EPHA4 Produkte)

Synonyme: HEK8 antikoerper, SEK antikoerper, TYRO1 antikoerper, RGD1560587 antikoerper, ephe antikoerper, EPHA4 antikoerper, Ci-Eph1 antikoerper, sek antikoerper, hek8 antikoerper, rtk1 antikoerper, tyr01 antikoerper, 2900005C20Rik antikoerper, AI385584 antikoerper, Cek8 antikoerper, Hek8 antikoerper, Sek antikoerper, Sek1 antikoerper, Tyro1 antikoerper, rb antikoerper, XEpha4 antikoerper, sek-1 antikoerper, epha4 antikoerper, pag antikoerper, EphA4 antikoerper, apha3 antikoerper, ek2 antikoerper, epha3 antikoerper, sb:cb246 antikoerper, zek2 antikoerper, zgc:109882 antikoerper, EPH receptor A4 antikoerper, Eph receptor A4 antikoerper, ephrin receptor epsilon antikoerper, EPH receptor A4 S homeolog antikoerper, EPH receptor A4 L homeolog antikoerper, eph receptor A4a antikoerper, EPHA4 antikoerper, Epha4 antikoerper, ephe antikoerper, epha4 antikoerper, epha4.S antikoerper, epha4.L antikoerper, epha4a antikoerper

Hintergrund: Protein kinases are enzymes that transfer a phosphate group from a phosphate donor, generally the g phosphate of ATP, onto an acceptor amino acid in a substrate protein. By this basic mechanism, protein kinases mediate most of the signal transduction in eukaryotic cells, regulating cellular metabolism, transcription, cell cycle progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation. With more than 500 gene products, the protein kinase family is one of the largest families of proteins in eukaryotes. The family has been classified in 8 major groups based on sequence comparison of their tyrosine (PTK) or serine/threonine (STK) kinase catalytic domains. The tyrosine kinase (TK) group is mainly involved in the regulation of cell-cell interactions such as differentiation, adhesion, motility and death. There are currently about 90 TK genes sequenced, 58 are of receptor protein TK (e.g. EGFR, EPH, FGFR, PDGFR, TRK, and VEGFR families), and 32 of cytosolic TK (e.g. ABL, FAK, JAK, and SRC families).

Molekulargewicht: 109860

Gen-ID: 2043

NCBI Accession: NP_004429

UniProt: P54764

Pathways: RTK Signalweg